卢拉西用于治疗精神分裂症:设计,开发和治疗中的位置
Itaru Miura1, Sho Horikoshi1,2, Mizue Ichinose1,3
1Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan.
Drug design, development and therapy
|October 4, 2023
概括
卢拉西有效地治疗精神分裂症症状,代谢副作用最小,在急性和长期治疗中为预防复发和改善认知功能提供好处.
科学领域:
- 药理学和精神病学 药理学和精神病学
- 药物开发 药物开发
- 精神分裂症治疗 治疗精神分裂症
背景情况:
- 精神分裂症需要长期抗精神病治疗,强调需要具有有利安全性概况的治疗方法,特别是在代谢副作用方面.
- 卢拉西的独特受体结合特征,包括对多巴胺D2和血清素5-HT2A/5-HT7受体的对抗性以及对5-HT1A的部分激动性,表明可以改善耐受性.
- 了解卢拉西的疗效和安全性对于优化精神分裂症管理至关重要.
研究的目的:
- 综合审查药物设计,开发和治疗治疗精神分裂症的卢拉西的应用.
- 根据随机对照试验和元分析,评估卢拉西在治疗急性精神分裂症症状中的疗效.
- 评估卢拉西的安全性,特别关注代谢副作用和长期结果.
主要方法:
- 在PubMed的文献搜索中查找关于精神分裂症中卢拉西的随机对照试验和元分析.
- 分析卢拉西的受体结合特征及其与治疗效果和副作用的相关性.
- 评估短期和长期研究数据的疗效,安全性,认知功能和复发预防.
主要成果:
- 短期研究表明,卢拉西在改善急性精神分裂症的整体精神病理,正面,负面和一般症状方面优于安慰剂.
- 卢拉西具有良好的安全性,具有最小的代谢副作用,包括体重增加,脂质异常和高血糖症.
- 用卢拉西长期治疗与复发预防和认知和功能表现的改善有关,具有持续的代谢耐受性.
结论:
- 卢拉西是急性精神分裂症治疗的有效一线选择,因为它的疗效和良性代谢特征.
- 它在长期使用中的安全性和有效性使其适合维持疗法,可能通过切换策略.
- 卢拉西为管理精神分裂症,改善症状,预防复发和增强认知功能提供了一个平衡的方法,同时尽量减少不良代谢影响.
相关概念视频
01:28Drug Therapy
60
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
60
01:26Psychosis: Goals of Pharmacotherapy
158
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
158
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
249
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
249
01:21Drugs for Treatment of Constipation-Predominant IBS
197
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
197
01:17Drugs for Treatment of Diarrhea-Predominant IBS
200
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
200
01:21Antipsychotic Drugs: Typical and Atypical Agents
234
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
234